Iovance Biotherapeutics, Inc. (IOVA)
8.06
-0.23
(-2.77%)
USD |
NASDAQ |
Aug 24, 16:00
8.05
-0.01
(-0.12%)
After-Hours: 04:58
Iovance Biotherapeutics Price : 8.06 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 8.08 | 8.36 | 7.79 | 8.06 | 15.73M |
| Aug 21, 2026 | 9.08 | 9.30 | 8.145 | 8.29 | 27.81M |
| Aug 20, 2026 | 8.07 | 9.36 | 7.96 | 8.99 | 43.81M |
| Aug 19, 2026 | 7.20 | 8.055 | 7.19 | 7.99 | 24.25M |
| Aug 18, 2026 | 7.00 | 7.31 | 6.931 | 7.03 | 10.50M |
| Aug 17, 2026 | 6.84 | 7.250 | 6.703 | 7.10 | 14.81M |
| Aug 14, 2026 | 6.52 | 7.00 | 6.36 | 6.98 | 17.51M |
| Aug 13, 2026 | 6.74 | 6.81 | 6.424 | 6.52 | 15.68M |
| Aug 12, 2026 | 6.49 | 6.74 | 6.39 | 6.74 | 13.46M |
| Aug 11, 2026 | 6.48 | 6.525 | 6.18 | 6.49 | 10.38M |
| Aug 10, 2026 | 6.31 | 6.61 | 6.16 | 6.40 | 17.31M |
| Aug 07, 2026 | 6.57 | 6.92 | 5.88 | 6.34 | 30.97M |
| Aug 06, 2026 | 5.95 | 6.39 | 5.63 | 6.21 | 73.43M |
| Aug 05, 2026 | 4.45 | 4.55 | 4.29 | 4.34 | 15.60M |
| Aug 04, 2026 | 4.39 | 4.48 | 4.29 | 4.36 | 10.68M |
| Aug 03, 2026 | 4.10 | 4.36 | 3.96 | 4.315 | 13.02M |
| Jul 31, 2026 | 4.43 | 4.55 | 4.02 | 4.07 | 19.97M |
| Jul 30, 2026 | 4.53 | 4.840 | 4.51 | 4.69 | 14.16M |
| Jul 29, 2026 | 4.73 | 4.78 | 4.495 | 4.56 | 10.79M |
| Jul 28, 2026 | 4.98 | 4.98 | 4.64 | 4.70 | 13.44M |
| Jul 27, 2026 | 5.02 | 5.16 | 4.855 | 4.90 | 13.25M |
| Jul 24, 2026 | 5.125 | 5.15 | 4.95 | 4.99 | 9.431M |
| Jul 23, 2026 | 5.03 | 5.275 | 5.00 | 5.13 | 9.732M |
| Jul 22, 2026 | 5.50 | 5.64 | 5.10 | 5.17 | 14.16M |
| Jul 21, 2026 | 5.07 | 5.53 | 5.02 | 5.48 | 20.35M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.67 |
| Amgen, Inc. | 443.84 |
| Neurocrine Biosciences, Inc. | 153.04 |
| Anika Therapeutics, Inc. | 21.34 |
| BioCryst Pharmaceuticals, Inc. | 9.68 |
Price Related Metrics
| PS Ratio | 10.17 |
| Price to Book Value | 4.960 |
| Earnings Yield | -8.95% |
| Market Cap | 3.651B |